Candriam Equities L Oncology Impact C
LU1864481541
Candriam Equities L Oncology Impact C/ LU1864481541 /
NAV 16.05.2024
Diff.+0,2200
Ertragstyp
Ausrichtung
Fondsgesellschaft
236,2900 USD
+0,09%
ausschüttend
Aktien
weltweit
Candriam ▶
Kennzahlen und Performance in:
Alle Kurse in USD
Tranchen
Titel
Ertragstyp
Rückn. Preis
1 Jahr
3 Jahre
Candriam Equities L Oncology Imp...
thesaurierend
2.400,9099
+7,62%
+6,05%
Candriam Equities L Oncology Imp...
thesaurierend
2.565,5000
+7,75%
+6,45%
Candriam Equities L Oncology Imp...
thesaurierend
207,9700
+4,02%
-4,87%
Candriam Equities L Oncology Imp...
thesaurierend
2.252,5000
+5,81%
+17,09%
Candriam Equities L Oncology Imp...
ausschüttend
1.611,3000
+7,27%
+5,03%
Candriam Equities L Oncology Imp...
thesaurierend
245,4500
+6,23%
+14,09%
Candriam Equities L Oncology Imp...
ausschüttend
236,2900
+6,27%
+2,13%
Candriam Equities L Oncology Imp...
ausschüttend
191,3300
+7,17%
+4,73%
Candriam Equities L Oncology Imp...
ausschüttend
20.796,0000
+3,23%
+2,32%
Candriam Equities L Oncology Imp...
thesaurierend
159,3600
+5,69%
+16,70%
Candriam Equities L Oncology Imp...
thesaurierend
2.114,3201
+5,00%
-2,15%
Candriam Equities L Oncology Imp...
thesaurierend
260,0600
+7,14%
+17,01%
Candriam Equities L Oncology Imp...
thesaurierend
207,4600
+3,60%
-5,99%
Candriam Equities L Oncology Imp...
thesaurierend
286,8900
+7,16%
+4,72%
Candriam Equities L Oncology Imp...
thesaurierend
194,1900
+4,88%
-
Candriam Equities L Oncology Imp...
thesaurierend
1.857,8800
+6,15%
-
Candriam Equities L Oncology Imp...
thesaurierend
2.884,1399
+7,27%
+5,03%
Candriam Equities L Oncology Imp...
thesaurierend
157,8100
-
-
Candriam Equities L Oncology Imp...
thesaurierend
274,5300
+6,26%
+2,11%
Performance
lfd. Jahr
+8,31%
6 Monate
+18,51%
1 Jahr
+6,27%
3 Jahre
+2,13%
5 Jahre
+58,81%
10 Jahre
-
seit Beginn
+70,35%
Jahr
2023
+0,17%
2022
-10,50%
2021
+2,49%
2020
+31,33%
2019
+30,34%
Ausschüttungen
29.04.2024
4,55 USD
28.04.2023
3,39 USD
28.04.2022
4,28 USD
28.04.2021
4,15 USD
24.04.2020
1,50 USD